BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16135181)

  • 1. Sarcoidosis caused by interferon therapy.
    Celik G; Sen E; Ulger AF; Kumbasar OO; Bozkaya H; Alper D; Karayalcin S
    Respirology; 2005 Sep; 10(4):535-40. PubMed ID: 16135181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Probable cutaneous sarcoidosis associated with combined ribavirin and interferon-alpha therapy for chronic hepatitis C].
    Savoye G; Goria O; Herve S; Riachi G; Noblesse I; Bastien L; Courville P; Lerebours E
    Gastroenterol Clin Biol; 2000; 24(6-7):679. PubMed ID: 10962394
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of subcutaneous sarcoid nodules induced by interferon-alpha].
    Ohhata I; Ochi T; Kurebayashi S; Masutani H; Kikui M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Oct; 32(10):996-1000. PubMed ID: 7844919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcoidosis occurring after interferon-alpha therapy for chronic hepatitis C: report of two cases.
    Hirano A; Kataoka M; Nakata Y; Takeda K; Kamao T; Hiramatsu J; Kimura G; Tanimoto Y; Kanehiro A; Tanimoto M
    Respirology; 2005 Sep; 10(4):529-34. PubMed ID: 16135180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcoid-related dacryoadenitis following treatment with interferon alpha and ribavarin for hepatitis C.
    Morley AM; O'Sullivan E; Thaung C; Malhotra R
    Orbit; 2011 Jan; 30(1):27-9. PubMed ID: 21281076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous lesions as initial signs of interferon alpha-induced sarcoidosis: report of three new cases and review of the literature.
    Fantini F; Padalino C; Gualdi G; Monari P; Giannetti A
    Dermatol Ther; 2009 Nov; 22 Suppl 1():S1-7. PubMed ID: 19891685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous sarcoidosis developing after treatment with pegylated interferon and ribavirin: a new case and review of the literature.
    López V; Molina I; Monteagudo C; Jordá E
    Int J Dermatol; 2011 Mar; 50(3):287-91. PubMed ID: 21342161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent antiphospholipid syndrome and cutaneous [corrected] sarcoidosis due to interferon alfa and ribavirin treatment for hepatitis C.
    Shinohara MM; Davis C; Olerud J
    J Drugs Dermatol; 2009 Sep; 8(9):870-2. PubMed ID: 19746680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of cutaneous sarcoidosis in a patient with chronic hepatitis C treated with interferon alpha 2b.
    Neglia V; Sookoian S; Herrera M; Abeldaño A; Kien MC; Chouela E; Frider B
    J Cutan Med Surg; 2001; 5(5):406-8. PubMed ID: 11915769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcoidosis on the injection sites following treatment of interferon-alpha and ribavirin for hepatitis C.
    Chiang CH; Lai FJ
    J Formos Med Assoc; 2014 Dec; 113(12):981-2. PubMed ID: 25187070
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term treatment with interferon-alpha can induce sarcoidosis. The connection can be stronger than earlier believed].
    Grunewald J; Andersson O; Berlin M; Bradley M; Zetterberg G; Weiland O; Eklund A
    Lakartidningen; 2006 Jun 28-Jul 11; 103(26-27):2045-8. PubMed ID: 16881277
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sarcoidosis induced by therapy with pegylated interferon alfa-2a].
    Bruch-Gerharz D; Reifenberger J
    Hautarzt; 2006 Apr; 57(4):317-35. PubMed ID: 16523277
    [No Abstract]   [Full Text] [Related]  

  • 13. Sarcoidosis and hepatitis C: clinical description of 11 cases.
    Faurie P; Broussolle C; Zoulim F; Trepo C; Sève P
    Eur J Gastroenterol Hepatol; 2010 Aug; 22(8):967-72. PubMed ID: 20216423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cutaneous sarcoidosis during pegylated interferon alpha and ribavirin treatment of chronic hepatitis C--a case report].
    Honsová E; Sticová E; Sperl J
    Cesk Patol; 2007 Jan; 43(1):27-30. PubMed ID: 17370474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C.
    Papaioannides D; Fotinou M; Korantzopoulos P; Latsi P; Sinapidis D; Akritidis N; Orphanidou D
    Med Sci Monit; 2004 Jan; 10(1):CS5-7. PubMed ID: 14704637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Systemic sarcoidosis during interferon-alpha therapy for chronic hepatitis C virus infection].
    Cacoub P; Sbaï A; Francès C; Génesti C; Hausfater P; Piette JC
    Gastroenterol Clin Biol; 2000 Mar; 24(3):364-6. PubMed ID: 10804348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papular Sarcoidosis of the Knees Following Treatment with Interferon Alpha and Ribavirin in a Woman with Hepatitis C.
    Monteagudo B; Grueiro MC; Vilas-Sueiro A; Campo-Cerecedo F
    Actas Dermosifiliogr (Engl Ed); 2019 Dec; 110(10):871-873. PubMed ID: 31387690
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pulmonal sarcoidosis: A rare side effect of interferon-alpha treatment for chronic hepatitis C infection].
    Pohl J; Stremmel W; Kallinowski B
    Z Gastroenterol; 2000 Dec; 38(12):951-5. PubMed ID: 11194885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcoidosis developing after treatment with interferon alpha in a patient with hepatitis C: An association every physician should know.
    Flores-Robles BJ; Sangüesa-Gómez CP; Barbadillo Mateos C; Roustán-Gullón LG; Kovtun I
    Rev Gastroenterol Mex; 2017; 82(2):185-186. PubMed ID: 27161792
    [No Abstract]   [Full Text] [Related]  

  • 20. Autoimmune thrombocytopenia induced by PEG-IFN-alpha plus ribavirin in hepatitis C.
    Demirturk N; Cevik F; Demirdal T; Aykin N; Aslan V
    Platelets; 2006 Aug; 17(5):340-3. PubMed ID: 16928608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.